A decade of R&D for Neglected Patients

[October 3, 2012]
DNDi Asia

Hotel Istana, Kuala Lumpur, Malaysia



Public event organized by DNDi and the Ministry of Health, Malaysia

Programme [PDF 6MB] 

Welcome address by Organising Chairman, Tan Sri Dato’ Seri Dr Haji Mohd Ismail Merican

Dr Bernard Pécoul, Executive Director, DNDi – Reflections on 10 Years of Challenges and
Successes of the DNDPartnership Model

Keynote address by the Right Honourable Dato’ Sri Mohd Najib bin Tun Abdul Razak, Prime Minister of Malaysia

Walking tour of photo exhibition: ‘A Decade of R&D for Neglected Patients in South East Asia’

10:30 – 11:10
Press Conference (media only)

Expert Panel: Strengthening the Portfolio of Fixed-Dose Combination ACTs – The Case of ASMQ

Dr Pierre-Etienne Bost, Chair, DNDi‘s Scientific Advisory Committee, formerly Institut Pasteur, France

  • WHO Recommendations for Malaria Treatment – Focus on ACTs – Dr Lasse Vestergaard, WHO Medical Officer, based in Manila WPRO office
  • ACTs for Malaria in South East Asia: Benefits and Challenges – Professor François Nosten, Shoklo Malaria Research Unit, Thailand
  • ASMQ FDC Development: A Partnership Approach [PDF] – Dr Jean-René Kiechel, Senior Pharma Advisor & Product Manager, DNDi
  • Technology Transfer of ASMQ from Malaysia to Brazil to India – Ana Rabello, Senior Researcher at Oswaldo Cruz Foundation – Fiocruz, Brazil
  • Investing in Neglected Diseases – ASMQ Implementation in South East Asia – Dr Jaideep Gogtay, Medical Director, Cipla Ltd, India
  • ASMQ in a South East Asia Public Health Perspective – Datuk Dr Lokman Hakim Sulaiman, Deputy Director General of Health, Malaysia